ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) Stock Price & Overview
NASDAQ:ZYBT • KYG989MS1016
Current stock price
The current stock price of ZYBT is 0.8901 USD. Today ZYBT is up by 1.23%. In the past month the price increased by 18.67%. In the past year, price decreased by -78.08%.
ZYBT Key Statistics
- Market Cap
- 42.182M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.03
- Dividend Yield
- N/A
ZYBT Stock Performance
ZYBT Stock Chart
ZYBT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ZYBT. When comparing the yearly performance of all stocks, ZYBT is a bad performer in the overall market: 94.95% of all stocks are doing better.
ZYBT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ZYBT. ZYBT has a bad profitability rating. Also its financial health evaluation is rather negative.
ZYBT Earnings
ZYBT Forecast & Estimates
ZYBT Groups
Sector & Classification
ZYBT Financial Highlights
Over the last trailing twelve months ZYBT reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -123.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.05% | ||
| ROE | -3.46% | ||
| Debt/Equity | 0.02 |
ZYBT Ownership
ZYBT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.52 | 882.589B | ||
| JNJ | JOHNSON & JOHNSON | 20.69 | 585.389B | ||
| MRK | MERCK & CO. INC. | 23.35 | 298.838B | ||
| PFE | PFIZER INC | 9.32 | 161.094B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.37 | 121.374B | ||
| ZTS | ZOETIS INC | 16.71 | 49.786B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.16 | 28.018B | ||
| VTRS | VIATRIS INC | 5.35 | 15.475B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.69 | 11.475B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.619B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.372B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.599B | ||
| CORT | CORCEPT THERAPEUTICS INC | 49.44 | 4.52B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ZYBT
Company Profile
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
Company Info
IPO: 2025-01-07
ZHENGYE BIOTECHNOLOGY HOLDIN
No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone
Jilin JILIN CN
Employees: 277
ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT FAQ
What does ZHENGYE BIOTECHNOLOGY HOLDIN do?
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
What is the stock price of ZHENGYE BIOTECHNOLOGY HOLDIN today?
The current stock price of ZYBT is 0.8901 USD. The price increased by 1.23% in the last trading session.
Does ZHENGYE BIOTECHNOLOGY HOLDIN pay dividends?
ZYBT does not pay a dividend.
What is the ChartMill technical and fundamental rating of ZYBT stock?
ZYBT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) based on its PE ratio?
ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
Is ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ZYBT.
Can you provide the ownership details for ZYBT stock?
You can find the ownership structure of ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) on the Ownership tab.